1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited

LALPATHLAB.NS
Dr. Lal PathLabs LimitedIN flagNational Stock Exchange of India
1,569.60
INR
+8.60
- -
262.09BMarket Cap

Total Valuation

Dr. Lal PathLabs Limited carries a market capitalization of 262.09B, placing it among publicly traded companies globally. Its enterprise value stands at 247.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap262.09B
Enterprise Value247.39B

Valuation Ratios

Dr. Lal PathLabs Limited trades at a trailing price-to-earnings ratio of 65.49.

PE Ratio65.49
PS Ratio12.80
PB RatioN/A
P/TBV RatioN/A
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Dr. Lal PathLabs Limited trades at an EV/EBITDA multiple of 56.96 and an EV/FCF ratio of 1,762.87. The EV/Sales ratio of 12.80 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 56.96 provides insight into valuation relative to core operating earnings.

EV / Sales12.80
EV / EBITDA56.96
EV / EBIT56.96
EV / FCF1,762.87

Financial Position

Dr. Lal PathLabs Limited maintains a current ratio of 3.39, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.13, indicating elevated leverage, while an interest coverage ratio of 25.69 demonstrates strong ability to service its debt obligations.

Current Ratio3.39
Quick Ratio2.89
Debt / Equity7.13
Debt / EBITDAN/A
Interest Coverage25.69

Taxes

Over the trailing twelve months, Dr. Lal PathLabs Limited has paid 779.47M in income taxes, reflecting an effective tax rate of 16.99.

Income Tax779.47M
Effective Tax Rate16.99

Stock Price Statistics

Dr. Lal PathLabs Limited's stock has gained approximately 11.16935% over the past 52 weeks. The 50-day moving average sits at 1,486.83, while the 200-day moving average is 1,491.58.

Beta (5Y)N/A
52-Week Price Change11.16935%
50-Day Moving Average1,486.83
200-Day Moving Average1,491.58
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Dr. Lal PathLabs Limited generated 19.32B in revenue and converted that into 3.78B in net income, yielding earnings per share of 22.78. EBITDA reached 4.34B, while operating income came in at 4.34B.

Revenue19.32B
Gross Profit12.91B
Operating Income4.34B
Pretax Income4.59B
Net Income3.78B
EBITDA4.34B
EBIT4.34B
Earnings Per Share (EPS)22.78

Margins

Dr. Lal PathLabs Limited operates with a gross margin of 66.83, reflecting its pricing power and cost economics. The operating margin of 22.48 and net profit margin of 19.55 provide insight into operational efficiency.

Gross Margin66.83
Operating Margin22.48
Pretax Margin23.75
Profit Margin19.55
EBITDA Margin22.48

Stock Splits

Dr. Lal PathLabs Limited's most recent stock split took place on December 19, 2025 with a 1:2 split ratio.

Last Split Date12/19/2025
Split Ratio1:2

Scores

Dr. Lal PathLabs Limited posts an Altman Z-Score of 4.21, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.21